Johannes Höfle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Johannes Höfle has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alexander H. Schmidt
DKMS Group, Tübingen, Germany
1 shared publication Angelique Hoelzemer
Leibniz Institute of Virology Hamburg Germany
1 shared publication- Annika Niehrs
Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
1 shared publication - Bryan Barcelona
University Medical Center Hamburg-Eppendorf
1 shared publication - Christian Körner
Leibniz Institute of Virology, Hamburg, Germany
1 shared publication - Jürgen Sauter
DKMS Group, Tübingen, Germany
1 shared publication
Latest Publications
- Open Access
- 27 June 2022
- Published by Springer Nature in EMBO Reports
- Vol. 23 (8) , e54133
Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells
NK cells utilize a large array of receptors to screen their surroundings for aberrant or virus‐infected cells. Given the vast diversity of receptors expressed on NK cells we seek to identify receptors involved in the recognition of HIV‐1‐infected cells. By combining an unbiased large‐scale screening approach with a functional assay, we identify TRAIL to be associated with NK cell degranulation against HIV‐1‐infected target cells. Further investigating the underlying mechanisms, we demonstrate that TRAIL is able to elicit multiple effector functions in human NK cells independent of receptor‐mediated induction of apoptosis. Direct engagement of TRAIL not only results in degranulation but also IFNγ production. Moreover, TRAIL‐mediated NK cell activation is not limited to its cognate death receptors but also decoy receptor I, adding a new perspective to the perceived regulatory role of decoy receptors in TRAIL‐mediated cytotoxicity. Based on these findings, we propose that TRAIL not only contributes to the anti‐HIV‐1 activity of NK cells but also possesses a multifunctional role beyond receptor‐mediated induction of apoptosis, acting as a regulator for the induction of different effector functions.
- 27 June 2022
- Published by Springer Nature in EMBO Reports
- Vol. 23 (8) , e54133
Open AccessEngagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells
NK cells utilize a large array of receptors to screen their surroundings for aberrant or virus‐infected cells. Given the vast diversity of receptors expressed on NK cells we seek to identify receptors involved in the recognition of HIV‐1‐infected cells. By combining an unbiased large‐scale screening approach with a functional assay, we identify TRAIL to be associated with NK cell degranulation against HIV‐1‐infected target cells. Further investigating the underlying mechanisms, we demonstrate that TRAIL is able to elicit multiple effector functions in human NK cells independent of receptor‐mediated induction of apoptosis. Direct engagement of TRAIL not only results in degranulation but also IFNγ production. Moreover, TRAIL‐mediated NK cell activation is not limited to its cognate death receptors but also decoy receptor I, adding a new perspective to the perceived regulatory role of decoy receptors in TRAIL‐mediated cytotoxicity. Based on these findings, we propose that TRAIL not only contributes to the anti‐HIV‐1 activity of NK cells but also possesses a multifunctional role beyond receptor‐mediated induction of apoptosis, acting as a regulator for the induction of different effector functions.